NAUT - Nautilus Biotechnolgy, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

NAUT

NAUTILUS BIOTECHNOLGY, INC.

NASDAQ

$0.89

▼ DOWN 2.04% (-0.02)

KEY STATISTICS

Market Cap$112.71 M

52w High$4.31

52w Low$0.62

Dividend Yield—

Frequency—

P/E-1.93

Volume484.07K

Shares Out.127.26M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Sujal Patel

COMPENSATION 2026

Salary$535,000

Stock Awards$0

Incentive Plan Pay$227,375

All Other Comp.$1,200

Total$1,418,556

ABOUT

SECTOR

Healthcare

WENT PUBLIC

August 7, 2020

METHOD OF GOING PUBLIC

SPAC

FULL TIME EMPLOYEES

127

PRICE TARGET

Target High$2.50

Target Low$2.50

Target Median$2.50

Target Consensus$2.50

UPCOMING EARNINGS

DateOct 27, 2026

DayTuesday

Rev. Est.$200.00K

OCT

TUE

PRICE

$0.89 ▼ DOWN 2.04% (−$0.02)

About Nautilus Biotechnolgy, Inc.

https://www.nautilus.bio ↗

Nautilus Biotechnology, founded in 2016 in Seattle, develops the Nautilus Platform—a comprehensive proteomics solution with instruments, consumables, and software—to quantify and analyze the proteome's complexity.

INDUSTRY

Biotechnology

A PRODUCT NAUTILUS BIOTECHNOLGY, INC. IS KNOWN FOR

Nautilus Proteome Analysis Platform

The Nautilus Proteome Analysis Platform is a life sciences instrument that uses 'Iterative Mapping' for detailed, scalable single-molecule protein analysis, aiming to democratize proteomics and advance biomarker discovery and drug development.